• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成骨不全症成年患者的股骨几何参数和 DXA 骨密度测量。

Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta.

机构信息

St. Vincent Hospital, Medical Department II, Academic Teaching Hospital of Medical University Vienna, The VINFORCE Study Group, Stumpergasse 13, 1060, Vienna, Austria.

出版信息

Skeletal Radiol. 2013 Feb;42(2):187-94. doi: 10.1007/s00256-012-1512-4. Epub 2012 Sep 7.

DOI:10.1007/s00256-012-1512-4
PMID:22955449
Abstract

OBJECTIVES

Osteogenesis imperfecta (OI) is an inherited disorder characterized by increased bone fragility with recurrent fractures that leads to skeletal deformities in severe cases. Consequently, in most OI patients, the hip is the only reliable measuring site for estimating future fracture risk. The aim of the study was to assess the applicability of hip structure analysis (HSA) by DXA in adult patients with osteogenesis imperfecta.

MATERIALS AND METHODS

We evaluated bone mineral density (BMD) and hip structure analysis (HSA) by DXA, including cross-sectional area (CSA), cross-sectional moment of inertia (CSMI) and femoral strength index (FSI) in 30 adult patients with different types of OI and 30 age-matched healthy controls (CO). The OI total group (OI-tot) was divided into two subgroups: the mild OI I group (OI-I) and the more severe OI III and IV group (OI-III-IV).

RESULTS

The mean neck BMD of OI-I and OI-III-IV were significantly lower compared to CO (-15.9 %, p < 0.005 and -37.5 %, p < 0.001 respectively). Similar results were observed at trochanter and total hip. CSA and the CSMI value were significantly lower for OI-I (-23.2 %, p < 0.001) and OI-III-IV (-45.9 %, p < 0.001) in comparison to CO. In addition, significant differences were found between the mild OI-I and the severe OI-III-IV group (-29.6 %, p < 0.05). FSI was significantly decreased in the OI-III-IV (25.7 %, p < 0.05) in comparison to the CO. Furthermore, significant correlations between BMD and HSA and between HSA and height and weight were found in osteogenesis imperfecta and controls.

CONCLUSION

BMD measurement in osteogenesis imperfecta patients is very critical. The combination of BMD and geometric structural measurements at the hip in osteogenesis imperfecta patients may represent an additional helpful means in estimating bone strength and fracture risk.

摘要

目的

成骨不全症(OI)是一种遗传性疾病,其特征是骨脆性增加,反复骨折,导致严重病例骨骼畸形。因此,在大多数 OI 患者中,髋关节是唯一可靠的测量部位,用于估计未来的骨折风险。本研究旨在评估 DXA 髋关节结构分析(HSA)在成骨不全症成年患者中的适用性。

材料和方法

我们评估了 30 名不同类型 OI 成年患者和 30 名年龄匹配的健康对照组(CO)的骨密度(BMD)和髋关节结构分析(HSA),包括横截面积(CSA)、横截面惯性矩(CSMI)和股骨强度指数(FSI)。OI 总组(OI-tot)分为两个亚组:轻度 OI I 组(OI-I)和更严重的 OI III 和 IV 组(OI-III-IV)。

结果

OI-I 和 OI-III-IV 的颈 BMD 平均值明显低于 CO(分别为-15.9%,p<0.005 和-37.5%,p<0.001)。在转子间区和全髋关节也观察到类似的结果。CSA 和 CSMI 值在 OI-I(-23.2%,p<0.001)和 OI-III-IV(-45.9%,p<0.001)与 CO 相比显著降低。此外,在轻度 OI-I 和严重 OI-III-IV 组之间也发现了显著差异(-29.6%,p<0.05)。与 CO 相比,OI-III-IV 的 FSI 明显降低(25.7%,p<0.05)。此外,在成骨不全症和对照组中,均发现 BMD 与 HSA 之间以及 HSA 与身高和体重之间存在显著相关性。

结论

在成骨不全症患者中,BMD 测量非常关键。在成骨不全症患者中,BMD 与髋关节的几何结构测量相结合,可能代表了一种额外的有用手段,用于估计骨强度和骨折风险。

相似文献

1
Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta.成骨不全症成年患者的股骨几何参数和 DXA 骨密度测量。
Skeletal Radiol. 2013 Feb;42(2):187-94. doi: 10.1007/s00256-012-1512-4. Epub 2012 Sep 7.
2
Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta.通过高分辨率外周定量计算机断层扫描(HR-pQCT)、骨小梁评分(TBS)和双能X线吸收法(DXL)评估不同类型成骨不全成年患者的骨结构。
Osteoporos Int. 2015 Oct;26(10):2431-40. doi: 10.1007/s00198-015-3156-4. Epub 2015 May 9.
3
Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.79名患有I型、III型和IV型成骨不全症的瑞典儿童接受帕米膦酸盐治疗后的骨折率降低、药物遗传学及骨密度反应
Bone. 2016 Jun;87:11-8. doi: 10.1016/j.bone.2016.02.015. Epub 2016 Mar 5.
4
Analysis of bone architecture using fractal-based TX-Analyzer™ in adult patients with osteogenesis imperfecta.应用基于分形学的 TX-AnalyzerTM 分析成骨不全症成年患者的骨结构。
Bone. 2021 Jun;147:115915. doi: 10.1016/j.bone.2021.115915. Epub 2021 Mar 13.
5
Imaging in osteogenesis imperfecta: Where we are and where we are going.成骨不全症的影像学表现:现状与未来。
Eur J Med Genet. 2024 Apr;68:104926. doi: 10.1016/j.ejmg.2024.104926. Epub 2024 Feb 16.
6
Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta.成骨不全症成人的骨量、骨标志物和骨折患病率。
Arch Osteoporos. 2011;6(1):31-8. doi: 10.1007/s11657-011-0054-z. Epub 2011 Apr 14.
7
THE CLINICAL CHARACTERISTICS AND EFFICACY OF BISPHOSPHONATES IN AUDLT PATIENTS WITH OSTEOGENESIS IMPERGECTA.双膦酸盐在成人成骨不全患者中的临床特征及疗效
Endocr Pract. 2016 Nov;22(11):1267-1276. doi: 10.4158/EP151184.OR. Epub 2016 Aug 2.
8
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.丹麦成骨不全患者的死亡率和发病率。
Dan Med J. 2018 Apr;65(4).
9
The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta.成骨不全症成年患者的骨体积密度和皮质厚度
J Clin Densitom. 2003 Summer;6(2):173-7. doi: 10.1385/jcd:6:2:173.
10
Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study.Setrusumab 治疗成骨不全症:2b 期小行星研究的 12 个月结果。
J Bone Miner Res. 2024 Sep 2;39(9):1215-1228. doi: 10.1093/jbmr/zjae112.

引用本文的文献

1
Bone health: Quality versus quantity.骨骼健康:质量与数量
J Pediatr Soc North Am. 2024 Apr 7;7:100054. doi: 10.1016/j.jposna.2024.100054. eCollection 2024 May.
2
Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta.骨质量和矿化及成骨不全症治疗的影响。
Calcif Tissue Int. 2024 Dec;115(6):777-804. doi: 10.1007/s00223-024-01263-8. Epub 2024 Sep 4.
3
Rare coexistence of hypopituitarism with osteogenesis imperfecta - A double-trouble for bone.垂体功能减退与成骨不全症的罕见共存——骨骼的双重麻烦。

本文引用的文献

1
Femoral neck bone strength estimated by hip structural analysis (HSA) in Swedish Caucasians aged 6-90 years.采用髋关节结构分析(HSA)评估瑞典白种人 6-90 岁人群的股骨颈骨强度。
Calcif Tissue Int. 2012 Mar;90(3):174-85. doi: 10.1007/s00223-011-9566-1. Epub 2012 Jan 22.
2
Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta.成骨不全症成人的骨量、骨标志物和骨折患病率。
Arch Osteoporos. 2011;6(1):31-8. doi: 10.1007/s11657-011-0054-z. Epub 2011 Apr 14.
3
Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.
Bone Rep. 2024 Apr 23;21:101768. doi: 10.1016/j.bonr.2024.101768. eCollection 2024 Jun.
4
Radiofrequency Echographic Multispectrometry (REMS): A New Option in the Assessment Bone Status in Adults with Osteogenesis Imperfecta.射频超声多光谱分析(REMS):评估成骨不全症成年患者骨状况的新方法。
J Imaging. 2023 Oct 3;9(10):210. doi: 10.3390/jimaging9100210.
5
An variant links aberrant Rac1 function to early-onset skeletal fragility.一种变异将异常的Rac1功能与早发性骨骼脆弱联系起来。
JBMR Plus. 2021 Jun 7;5(7):e10509. doi: 10.1002/jbm4.10509. eCollection 2021 Jul.
6
The role of carboxy-terminal cross-linking telopeptide of type I collagen, dual x-ray absorptiometry bone strain and Romberg test in a new osteoporotic fracture risk evaluation: A proposal from an observational study.I型胶原羧基末端交联肽、双能X线吸收法骨应变及闭目直立试验在骨质疏松性骨折新风险评估中的作用:一项观察性研究的提议
PLoS One. 2018 Jan 5;13(1):e0190477. doi: 10.1371/journal.pone.0190477. eCollection 2018.
7
Bone mass and mineralization in osteogenesis imperfecta.成骨不全症中的骨量与矿化
Wien Med Wochenschr. 2015 Jul;165(13-14):271-7. doi: 10.1007/s10354-015-0369-2. Epub 2015 Jul 25.
8
Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta.通过高分辨率外周定量计算机断层扫描(HR-pQCT)、骨小梁评分(TBS)和双能X线吸收法(DXL)评估不同类型成骨不全成年患者的骨结构。
Osteoporos Int. 2015 Oct;26(10):2431-40. doi: 10.1007/s00198-015-3156-4. Epub 2015 May 9.
9
Managing osteoporosis in ulcerative colitis: something new?溃疡性结肠炎患者骨质疏松症的管理:有新进展吗?
World J Gastroenterol. 2014 Oct 21;20(39):14087-98. doi: 10.3748/wjg.v20.i39.14087.
利塞膦酸盐治疗 I 型成骨不全症成人患者:增加骨密度和减少骨转换,但骨折率仍居高不下。
Osteoporos Int. 2012 Jan;23(1):285-94. doi: 10.1007/s00198-011-1658-2. Epub 2011 Jul 8.
4
New perspectives on osteogenesis imperfecta.成骨不全症的新视角。
Nat Rev Endocrinol. 2011 Jun 14;7(9):540-57. doi: 10.1038/nrendo.2011.81.
5
COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.COL1 C-前肽切割位点突变导致高骨量型成骨不全症。
Hum Mutat. 2011 Jun;32(6):598-609. doi: 10.1002/humu.21475. Epub 2011 Apr 7.
6
Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study.桡骨远端和女性股骨死后皮质内改建和孔隙率的横断面研究。
Lancet. 2010 May 15;375(9727):1729-36. doi: 10.1016/S0140-6736(10)60320-0.
7
Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding.骨不全症伴正常胶原折叠中环孢素 B 的缺乏。
N Engl J Med. 2010 Feb 11;362(6):521-8. doi: 10.1056/NEJMoa0907705. Epub 2010 Jan 20.
8
Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.成骨不全症患者的软骨 II 型胶原蛋白降解增加,可作为骨 I 型胶原蛋白改变的人类模型。
Bone. 2010 Apr;46(4):897-900. doi: 10.1016/j.bone.2009.12.003. Epub 2009 Dec 11.
9
A comparative study between corresponding structural geometric variables using 2 commonly implemented hip structural analysis algorithms applied to dual-energy X-ray absorptiometry images.使用两种常用的髋部结构分析算法对双能 X 射线吸收法图像进行分析,比较相应的结构几何变量。
J Clin Densitom. 2009 Oct-Dec;12(4):461-7. doi: 10.1016/j.jocd.2009.08.004.
10
Classification of Osteogenesis Imperfecta revisited.成骨不全的分类再探讨。
Eur J Med Genet. 2010 Jan-Feb;53(1):1-5. doi: 10.1016/j.ejmg.2009.10.007. Epub 2009 Oct 28.